Anticoagulants Flashcards
What are Anticoagulants?
Prevent thrombus formation and extension by inhibiting clotting factors e.g. heparin, low molecular weight heparin, coumarins/ warfarin.
What are Antiplatelet drugs?
reduce risk of clot formation by inhibiting platelet functions e.g. aspirin and ticlopidine.
What are Fibrinolytic agents?
dissolve thrombi already formed e.g. streptokinase.
List all 13 coagulation factors and their names
I Fibrinogen
II Prothrombin
III Tissue Factor or thromboplastin
IV Ca++
V Proaccelerin
VII Proconvertin
VIII Antihemophilic A factor
IX Antihemophilic B factor or Christmas factor
X Stuart or Stuart- Prower factor
XI Plasma thomboplastin antecedent
XII Hageman factor, contact factor
XIII Fibrin stabilizing factor
Prekallikrein factor
High-molecular-weight kininogen
What are 3 endogenous Inhibitors of Coagulation?
- Antithrombin III, is a plasma protein that inhibits activated thrombin (factor IIa) and Xa, it is the site of action of heparin
- Prostacyclin ( PGI2), is synthesized by endothelial cells and inhibits platelet aggregation
- Protein C and Protein S: degrading Factor VIIIa and Va preventing coagulation
Types of anticoagulants
Parenteral anticoagulants:
Direct e.g hirudin, lepirudin
Indirect e.g heparin and heparin related agents
Oral Anticoagulants:
Vitamin K antagonists e.g. warfarin
Anticoagulants are indicated in
Myocardial infarction (MI)
Deep venous thrombosis (DVT)
Peripheral arterial emboli, pulmonary embolism (PE) and many other conditions
Anticoagulants are also useful in dialysis procedures
What is Heparin (Unfractionated Heparin)?
Normally occurs as macromolecule in mast cells with histamine ( its physiological role is unknown )
Commercial preparations are extracted from beef lung or pig intestine (can cause hypersensitivity reaction)
Heparin stops the expansion of a thrombus and prevents the formation of new thrombi but it does not dissolve an existing thrombus
What is Heparin’s Mechanism of action
Indirect Thrombin Inhibitor
It acts indirectly by increasing the activity of the endogenous anticoagulant “antithrombin III” (1000 folds) which inhibits activated clotting factors mainly thrombin (factor IIa) and Xa
When Heparin binds to antithrombin III, it causes conformational changes that accelerates its rate of action 1000 fold
Heparin binds to both antithrombin III and thrombin to form a ternary complex
Heparin dissociates leaving the thrombin bound to its inhibitor
Once dissociated, Heparin is free to bind to another antithrombin molecule and subsequently inhibits more thrombin
Discuss the Pharmacokinetics of UFH
- Heparin is not absorbed from the GIT
- It should be administered by IV or SC injection.
- Not injected IM as it causes haematomas at injection site
- Once in the blood stream, UFH binds to plasma proteins, endothelial cells and macrophages
- Heparin does not cross the placenta; therefore it is the drug of choice as anticoagulat during pregnancy
- Close monitoring of the activated partial thromboplastin time (aPTT) is necessary in patients receiving UFH.
Therapeutic uses of heparin
Due to its rapid onset of action, it is used to initiate immediate anticoagulation in thromboembolic disease (PE, DVT, MI) mainly as induction for oral vitamin K antagonists (VKAs)
Prevention of postoperative DVT (in patient undergoing hip replacement)
Prevention of coagulation during renal dialysis or cardiac surgery
Disadvantages of UFH
The inconvenience of administration by injection
The need for regular monitoring (aPTT)
UFH carries a risk of heparin-induced thrombocytopenia (HIT), a fall in the platelet count and increased risk of thrombosis due to binding to platelets
Generally, if the number of platelets is too low, excessive bleeding can occur
If the number of platelets is too high, blood clots can form thrombosis
However, there are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) that typically cause thrombosis, or clots, instead of bleeding
Adverse effects of UFH
The major adverse effect of heparin is bleeding
Allergic reactions (chills, fever, urticaria) as heparin is of animal origin and should be used cautiously in patients with allergy
Long-term heparin therapy is associated with osteoporosis
Heparin-induced thrombocytopenia (HIT )
Heparin-Induced Thrombocytopenia
Generally, if the number of platelets is too low, excessive bleeding can occur
If the number of platelets is too high, blood clots can form thrombosis
However, there are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) that typically cause thrombosis, or clots, instead of bleeding
Contraindications of Heparin
Bleeding disorders, hemophilia
Patients with hypersensitivity to the drug
Recent surgery of the brain, eye or spinal cord, threatened abortion